14 September 2022 | Other

BA.4/5-adjusted COVID booster by Pfizer/BioNTech approved by European Union regulator

Just a few days after the EMA (European Medicines Agency) approved several boosters, which were specifically aimed at protecting from the old Omicron version BA.1, a new Covid-19 booster developed for targeting the presently spreading versions BA.⅘ have been recommended for use.

The recommendation applies to a bivalent type of vaccine, created by Pfizer and BioNTech particularly for the BA.⅘ version and also the initial viral strain, appeared in China at the end of 2019.

The recommendation implies the authorization of the use of said booster for further vaccinating of persons older than 12, who have already received at least one COVID-19 vaccination. It’s required for the booster to get an approval from European Commission, which is expected to take place soon.

According to the statement made by Pfizer, if the booster gets the necessary permissions, it will be made available in each of the European Union countries shortly after.

Company MarketCheese
Period: 08.07.2025 Expectation: 1500 pips
EURUSD rally faces potential correction toward 1.165
Yesterday at 06:46 AM 47
Period: 09.07.2025 Expectation: 1400 pips
USDCAD declines amid US dollar weakness and improving Canadian trade prospects
Yesterday at 06:07 AM 34
Period: 08.07.2025 Expectation: 3000 pips
Buying Bitcoin during consolidation before July growth wave with 110,000 target
01 July 2025 60
Period: 07.07.2025 Expectation: 2000 pips
Renewed tensions between Musk and Trump weigh on Tesla shares
01 July 2025 50
Period: 07.07.2025 Expectation: 1900 pips
SPX may retreat to 5,980 following all-time high
30 June 2025 56
Gold sell
Period: 04.07.2025 Expectation: 5000 pips
Gold's six-month uptrend is under threat as prices test 3250 level
30 June 2025 174
Go to forecasts